Vejle, Syddanmark, Denmark Vecata appeared to be the VC, which was created in 2003. The venture was found in Europe in Denmark. Vecata appeared to be a CVC structure as part of the corporation. The main office of represented VC is situated in the Vejle.
Comparing to the other companies, this Vecata performs on 21 percentage points more the average number of lead investments. The increased amount of exits for fund were in 2012. The fund is generally included in less than 2 deals every year. The top activity for fund was in 2005. The usual things for fund are deals in the range of 5 - 10 millions dollars.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Vecata, startups are often financed by Seventure Partners, Incuba Venture. The meaningful sponsors for the fund in investment in the same round are Incuba Venture, Seventure Partners, VIA Equity. In the next rounds fund is usually obtained by VF Venture, Seventure Partners, Danish Venture Capital and Private Equity Association.
Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - Denmark. We can highlight the next thriving fund investment areas, such as CRM, Natural Resources. Among the various public portfolio startups of the fund, we may underline Zoomio Holding, LiPlasome Pharma, Fluxome
Related Funds
Funds with similar focus
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
FlexFunding | 01 Dec 2017 | Hovedstaden, Capital Region of Denmark, Denmark | |||
Fluxome | $15M | 23 Jul 2008 | Denmark, Capital Region of Denmark, Denmark | ||
LiPlasome Pharma | $8M | 01 Mar 2005 | Vejle, Region of Southern Denmark, Denmark |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
FlexFunding | 01 Dec 2017 | Hovedstaden, Capital Region of Denmark, Denmark | |||
Fluxome | $15M | 23 Jul 2008 | Denmark, Capital Region of Denmark, Denmark | ||
LiPlasome Pharma | $8M | 01 Mar 2005 | Vejle, Region of Southern Denmark, Denmark |
